Abbvie Vice Chairman Severino Departs for Flagship Pioneering
April 13 2022 - 10:19AM
Dow Jones News
By Will Feuer
Abbvie Inc. Vice Chairman Michael Severino is leaving the
company, effective May 31, to join bioplatform innovation firm
Flagship Pioneering as chief executive-partner, the companies
said.
Dr. Severino will also serve as CEO of one of Flagship's
companies, which hasn't yet been announced, the company said.
"I look forward to applying my experience across all phases of
drug discovery, development, and commercialization at Flagship, to
help make an important difference for patients," Dr. Severino
said.
Dr. Severino joined AbbVie in 2014 as executive vice president
of research and development and chief scientific officer. Before
joining AbbVie, Dr. Severino was corporate chief medical officer at
Amgen Inc.
Flagship Pioneering, founded by Noubar Afeyan in 2000, has
invested billions in dozens of bipharmaceutical firms, including
various public companies like Axcella Health Inc., Codiak
BioSciences Inc. and others.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
April 13, 2022 10:04 ET (14:04 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jun 2024 to Jul 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jul 2023 to Jul 2024